(Q34123525)
Statements
Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression (English)
Samuel Refetoff
1 reference
Devora Champa
Marika A Russo
Xiao-Hui Liao
Ronald A Ghossein
1 reference